The present invention relates to a fusion protein comprising at least two cytokines of which at least one is a modified cytokine with a strongly reduced binding affinity to its receptor or to one of its receptors. Preferably both cytokines are connected by a linker preferably a GGS linker. The invention relates further to said fusion protein for use in treatment of diseases.